Although there is still a discrepancy in the relationships between visfatin, glucose metabolism, and lipid profiles, the results of the meta-analysis still show that an elevated visfatin level is higher in subjects with obesity, T2D, metabolic syndrome (MetS), and cardiovascular disease [8]. Here, NAMPT is linked to obesity due to melanocortin 4 receptor deficiency.